In an ideal laboratory setting, genomic and transcriptomic analyses are performed on "fresh-frozen" tissue—samples immediately plunged into liquid nitrogen to halt biological activity. However, the vast majority of the world’s biological data exists in a state of decay. Clinical archives are filled with formalin-fixed, paraffin-embedded (FFPE) blocks; environmental surveys grapple with wastewater and stool samples; and field researchers must contend with post-mortem intervals and extreme environmental shifts.
The central challenge in this research direction is molecular recovery: the development of assays and computational models that can extract high-fidelity signals from fragmented, cross-linked, and chemically modified biological material.
The Formalin Barrier and Short-Sequence Targeting
For decades, the standard for clinical pathology has been FFPE preservation. While excellent for maintaining tissue structure, formalin causes severe DNA/RNA cross-linking and fragmentation. As Craig April and colleagues noted in Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples, this process destroys the poly-A tails required by standard sequencing methods.
To bypass this, researchers have shifted from seeking "whole" molecules to targeting short, specific sequences. Jérôme Toussaint demonstrated this by distilling a complex 97-gene breast cancer signature into an 8-gene qRT-PCR test in Improvement of the clinical applicability of the Genomic Grade Index. By focusing on small, robust targets, these "distilled" assays maintain accuracy even when the underlying genetic material is heavily degraded. Similarly, Xiaoxiao Li showed that Nanopore Amplicon Sequencing can outperform traditional RT-qPCR for viral detection by "tiling" the entire genome, allowing for the reconstruction of signals from fragmented viral RNA in Rapid and Accurate Detection of SARS Coronavirus 2 by Nanopore Amplicon Sequencing.
Replacing Destructive Chemistry with Gentle Alternatives
A second major hurdle is the "chemical paradox": many traditional methods for measuring molecular modifications actually destroy the sample. For example, bisulfite sequencing—the gold standard for DNA methylation—uses harsh reagents that degrade up to 90% of the DNA. This is particularly devastating for cell-free DNA (cfDNA) or small biopsies.
Researchers are now moving toward "gentle" enzymatic methods. Jiangfeng Shen utilized enzymatic methyl sequencing to preserve DNA signals in liquid biopsies for esophageal cancer in Improved circulating tumor DNA identification. By avoiding chemical degradation, these methods allow for the simultaneous acquisition of high-quality sequence data and epigenetic information from the same molecule, a feat previously difficult to achieve as noted by Arjun S. Nanda in Direct transposition of native DNA for sensitive multimodal single-molecule sequencing.
Computational Inference from Fragmentation Patterns
Perhaps the most innovative shift is treating degradation not as a "bug," but as a "feature." When DNA circulates in the blood or sits in a cell, it is wrapped around proteins (nucleosomes) that protect it from enzymes. The "fragmentation pattern"—where the DNA breaks—is therefore not random; it is a footprint of the cell's internal structure.
In FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA, Yaping Liu and Sarah C. Reed introduced a machine learning model that predicts methylation directly from these fragmentation patterns. This allows scientists to extract epigenetic insights from standard, non-destructive sequencing data, effectively "rescuing" information from millions of existing datasets that were previously thought to be epigenetically silent.
Overcoming Environmental and Post-Mortem Decay
The urgency of this research is most visible in field and clinical settings where "ischemia time"—the delay between death or sampling and preservation—is unavoidable. John T. Lonsdale and the GTEx project highlighted how rapid post-mortem RNA degradation can obscure the physiological state of living tissue.
Solutions here range from logistical to technological. In the deep sea, John A. Burns utilized in situ preservation to capture the transcriptomes of fragile invertebrates before they could degrade during the ascent to the surface in Transcriptome sequencing of seven deep marine invertebrates. In clinical diagnostics, Jindong Wang has advocated for alcohol-based fixation in Cytopathology, which preserves DNA integrity far better than traditional formalin, providing a superior substrate for next-generation sequencing.
By combining optimized sampling, gentle chemistry, and predictive modeling, this field is turning "uninterpretable" degraded samples into a rich resource for precision medicine and evolutionary biology.